Abstract
OBJECTIVE: The goal of this study was to determine the effect of marijuana use on the risk of young-onset IS among Caucasians and African-Americans. BACKGROUND: The association between marijuana use and ischemic stroke (IS) risk remains controversial. DESIGN/METHODS: 1,101 cases and 1,154 controls, aged 15-49 years old, were recruited from the greater Baltimore-Washington area between 1992-2008. Subjects were interviewed to assess the presence of stroke risk factors and history of illicit drug use. Participants who used any illicit drug other than marijuana or hashish were excluded from the analyses, resulting in 783 cases and 794 controls for analyses. Logistic regression was used to determine the association between marijuana/hashish use and IS. RESULTS: 35% of cases and 37% of controls reported ever using marijuana or hashish. Men were more likely than women to report a history of marijuana or hashish use (41% vs. 32%; p<0.0001), and African-Americans less likely than Caucasians (32% vs. 40%; p=0.003). Having a history of marijuana/hashish use was not associated with IS in the overall sample or any gender-/ethnic-specific subgroup. Evaluating the timing of last use, stroke risk was not significantly increased among those who used marijuana or hashish in the year prior (OR=1.54; 95%CI=0.77-3.09), in the month prior (OR=0.96; 95%CI=0.47-1.95), or within 24 hours prior (OR=0.92; 95%CI=0.30-2.83) to stroke onset after adjustment for age, gender and current smoking. Compared with persons who did not use marijuana or hashish in the past year, there was an increased risk of stroke among frequent users (蠅1.88 times per month), but not among non-frequent users (< 1.88 times per month), although neither association was statistically significant (adjusted OR=1.56; 95%CI=0.79-3.06 vs. OR=0.55; 95%CI=0.26-1.20, respectively). CONCLUSION: Our data does not demonstrate a risk of ischemic stroke as associated with marijuana use. Additional studies are warranted examining the effect of heavy or frequent use.
Disclosure: Dr. Dutta has nothing to disclose. Dr. Ryan has nothing to disclose. Dr. Cheng has nothing to disclose. Dr. Kittner has nothing to disclose. Dr. Cole has received research support from the University of Maryland.
Thursday, May 1 2014, 3:15 pm-5:00 pm
- Copyright © 2014 by AAN Enterprises, Inc.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
